Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
1.
J Med Ultrasound ; 32(2): 110-115, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38882609

RESUMO

With an estimated prevalence of 1 in 1000 individuals globally, autosomal dominant polycystic kidney disease (ADPKD) stands as the most prevalent inherited renal disorder. Ultrasonography (US) is the most widely used imaging modality in the diagnosis and monitoring of ADPKD. This review discusses the role of US in the evaluation of ADPKD, including its diagnostic accuracy, limitations, and recent advances. An overview of the pathophysiology and clinical manifestations of ADPKD has also been provided. Furthermore, the potential of US as a noninvasive tool for the assessment of disease progression and treatment response is examined. Overall, US remains an essential tool for the management of ADPKD, and ongoing research efforts are aimed at improving its diagnostic and prognostic capabilities.

2.
BMC Nephrol ; 19(1): 109, 2018 05 08.
Artigo em Inglês | MEDLINE | ID: mdl-29739354

RESUMO

BACKGROUND: This study aimed to evaluate the longitudinal changes in cardiac structure and function in incident-automated peritoneal dialysis (APD) patients. METHODS: We conducted a 2-year prospective, randomized, open-label, parallel-group study to compare the efficacy of icodextrin solution versus glucose-based solution. Echocardiography was performed at baseline, 1 and 2 years. Echocardiographic parameters over 2 years were evaluated for each group, using the Friedman test. Generalized linear regression analysis was used to test the associations between baseline clinical variables and echocardiographic changes, and a multivariate model was used to analyze cardiac function between the two groups. RESULTS: A total of 43 APD patients were enrolled in the beginning of this study. Twenty patients in the icodextrin group (ICO) and 18 patients in the glucose group (GLU) completed the study. In left ventricular (LV) systolic function measurements, ejection fraction (EF) increased significantly in the GLU group. Measurements of LV diastolic function and septal early mitral annulus velocity (EMV) increased significantly from baseline to 24-months in the ICO group (5.43-5.51 ms). The GLU group showed a significant decrease in peak early diastolic velocity (EDV) (70.67-68.25 cm/s), but a significant increase in septal EMV (5.94-7.57 ms) from baseline to 24-months. No significant association was found between the baseline clinical variables and echocardiographic changes within 24 months in the generalized linear regression analysis. Multivariate models were used to investigate changes in the four primary endpoints, namely, myocardial performance index (MPI), left ventricular ejection fraction (LVEF), deceleration time (DT), and E/e' ratio. These primary endpoints show no significant association with the baseline values in both the ICO and GLU groups. CONCLUSION: The present study demonstrates that long-dwell icodextrin solution can maintain reasonable cardiac structure and function in incident-APD patients. TRIAL REGISTRATION: ISRCTN14931270 (retrospectively registered on 23/03/2018).


Assuntos
Soluções para Diálise/administração & dosagem , Glucose/administração & dosagem , Coração/diagnóstico por imagem , Icodextrina/administração & dosagem , Diálise Peritoneal/tendências , Feminino , Coração/efeitos dos fármacos , Coração/fisiologia , Cardiopatias/diagnóstico por imagem , Cardiopatias/terapia , Humanos , Incidência , Nefropatias/diagnóstico por imagem , Nefropatias/terapia , Estudos Longitudinais , Masculino , Diálise Peritoneal/efeitos adversos , Estudos Prospectivos , Função Ventricular Esquerda/efeitos dos fármacos , Função Ventricular Esquerda/fisiologia
3.
Int J Med Sci ; 13(2): 92-8, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26941566

RESUMO

BACKGROUND: Vascular calcification (VC) is a key process associated with cardiovascular mortality in dialysis patients. Gelsolin is an actin-binding protein that can modulate inflammation, correlated inversely with hemodialysis (HD) mortality and involved in bone calcification homeostasis. In this report, we aim to characterize progression in aortic arch calcification (AAC) and investigate its association with gelsolin. METHODS: 184 HD patients were enrolled and their annual posterior-anterior chest X-ray films (CXR) in 2009 and 2013 were examined. The severity of AAC was classified as grade 0 to 3. Blood levels of gelsolin were measured by ELISA kits. Biographic and biochemical data at baseline were analyzed with status of AAC at baseline and changes after 4 years. RESULTS: At baseline, 60% of the patients had detectable AAC on CXR. After 4 years, 77% had AAC. Patients with grade 1 and 2 AAC had increased risk of progression (Odds ratio [OR] 2~3, P=0.001) compared to those with grade 0 at baseline. Compared to those with no AAC, patients with AAC progression had older age, lower gelsolin, higher waist circumference and prevalence of vascular disease. Regression analysis confirmed baseline gelsolin (odds ratio 0.845, 95% confidence interval [0.734-0.974]) and waist circumference as the independent factors associated with AAC progression. Gelsolin is positively correlated with serum albumin and negatively with tumor necrosis factor-alpha. CONCLUSION: Our study demonstrated that HD patients with grades 1 or 2 baseline AAC are at increased risk of further progression compared to those with grade 0. We also found lower blood levels of gelsolin associated with progressive AAC. Further investigation into the mechanistic roles of gelsolin in vascular calcification may provide new understanding of this key process.


Assuntos
Aorta Torácica/fisiopatologia , Gelsolina/sangue , Diálise Renal/efeitos adversos , Calcificação Vascular/etiologia , Adulto , Idoso , Aorta Torácica/diagnóstico por imagem , Biomarcadores/sangue , Humanos , Pessoa de Meia-Idade , Radiografia Torácica , Calcificação Vascular/diagnóstico por imagem
4.
Artif Organs ; 39(2): 150-5, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25039281

RESUMO

Protein-energy wasting (PEW) contributes to mortality in hemodialysis (HD) patients. Adipokines regulate energy homeostasis and body weight. Circulating gelsolin can modulate inflammation and is correlated with HD mortality. Whether adipokines and gelsolin play important roles in PEW remains unclear. Based on the criteria proposed by the International Society of Renal Nutrition and Metabolism, we examined the associations between PEW and biomarkers (gelsolin, leptin, adiponectin, interleukin-6, tumor necrosis factor alpha [TNF-α]) in 188 stable HD patients. Patients with PEW had significantly lower serum leptin levels, and tended to have higher adiponectin, TNF-α, and lower gelsolin levels. Logistic regression analysis revealed that gelsolin, leptin, adiponectin, and blood urea nitrogen were independently associated with PEW score. Serum creatinine, TNF-α, gender, renin-angiotensin system (RAS) blockade, and lipid-lowering agents were not associated with PEW score. Patients on lipid-lowering agents had lower PEW scores and those with RAS blockade had higher PEW scores. Our study confirms that gelsolin, adiponectin, and leptin are significant associates with PEW in HD patients. Further understanding of how these factors contribute to PEW may help design novel therapeutic strategies for PEW in chronic kidney disease.


Assuntos
Adipocinas/sangue , Gelsolina/sangue , Desnutrição Proteico-Calórica/sangue , Diálise Renal , Insuficiência Renal Crônica/complicações , Insuficiência Renal Crônica/terapia , Idoso , Biomarcadores/sangue , Feminino , Humanos , Interleucina-6/sangue , Leptina/sangue , Masculino , Pessoa de Meia-Idade , Desnutrição Proteico-Calórica/etiologia , Insuficiência Renal Crônica/sangue , Fator de Necrose Tumoral alfa/sangue
5.
Blood Purif ; 37(1): 76-83, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24576840

RESUMO

BACKGROUND: Removal of protein-bound uremic toxins by dialysis therapy is limited. The effect of oral adsorbent AST-120 in chronic dialysis patients has rarely been investigated. METHODS: AST-120 was administered 6.0 g/day for 3 months in 69 chronic dialysis patients. The blood concentrations of indoxyl sulfate, p-cresol sulfate and biomarkers of cardiovascular risk were determined before and after AST-120 treatment. RESULTS: AST-120 significantly decreased both the total and free forms of indoxyl sulfate and p-cresol sulfate ranging from 21.9 to 58.3%. There were significant simultaneous changes of the soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK, 24% increase), malondialdehyde (14% decrease) and interleukin-6 (19% decrease). A significant association between the decrease of indoxyl sulfate and changes of sTWEAK and interleukin-6 was noted. CONCLUSIONS: AST-120 effectively decreased indoxyl sulfate and p-cresol sulfate levels in both total and free forms. AST-120 also improved the profile of cardiovascular biomarkers.


Assuntos
Carbono/uso terapêutico , Doenças Cardiovasculares/sangue , Cresóis/sangue , Indicã/sangue , Falência Renal Crônica/terapia , Óxidos/uso terapêutico , Diálise Renal , Ésteres do Ácido Sulfúrico/sangue , Uremia/terapia , Adsorção , Adulto , Biomarcadores/sangue , Carbono/administração & dosagem , Doenças Cardiovasculares/etiologia , Cresóis/isolamento & purificação , Citocina TWEAK , Feminino , Humanos , Indicã/isolamento & purificação , Interleucina-6/sangue , Falência Renal Crônica/sangue , Falência Renal Crônica/complicações , Masculino , Malondialdeído/sangue , Pessoa de Meia-Idade , Óxidos/administração & dosagem , Ligação Proteica , Fatores de Risco , Ésteres do Ácido Sulfúrico/isolamento & purificação , Fatores de Necrose Tumoral/sangue , Uremia/sangue , Uremia/complicações
6.
BMC Nephrol ; 14: 185, 2013 Sep 04.
Artigo em Inglês | MEDLINE | ID: mdl-24007461

RESUMO

BACKGROUND: The aim of this study was to evaluate whether a high baseline level of high-sensitivity C-reactive protein (hs-CRP) or changes in the level predicts the risk of peritonitis in patients on continuous ambulatory peritoneal dialysis (CAPD). METHODS: A prospective, cross-sectional, case-control study was conducted in a single hospital-based PD unit. A total of 327 patients were included in the study. Serum hs-CRP was measured annually for 2 years. Patients were divided into 4 groups according to the changes in annual hs-CRP levels (at baseline and at 1 year intervals): group 1 (from <5 mg/L to <5 mg/L, n = 171), group 2 (from <5 mg/L to ≥5 mg/L, n = 45), group 3 (from ≥5 mg/L to <5 mg/L, n = 45), and group 4 (from ≥5 mg/L to ≥5 mg/L, n = 80). Demographics, biochemistry results, PD adequacy indices, and peritonitis risk were compared between the groups. RESULTS: The initial serum albumin level was similar in the 4 groups (p = 0.12). There was a negative linear correlation between the serial albumin change (∆alb) and serial hs-CRP change (∆hs-CRP; r = -0.154, p = 0.005). The hazard ratio (HR) for peritonitis was significantly higher in group 2 (HR = 1, reference) than in group 4 (HR = 0.401, 95% CI 0.209 - 0.769). Group 2 had a greater serum albumin decline rate (∆alb: -3% ± 9%) and hs-CRP elevation rate (∆hs-CRP: 835% ± 1232%) compared to those for the other groups. CONCLUSIONS: A progressive increase in the hs-CRP level was associated with a corresponding decline in the serum albumin level. Progressive rather than persistently high levels of serum hs-CRP predicted peritonitis risk in CAPD patients.


Assuntos
Proteína C-Reativa/análise , Periostite/sangue , Periostite/epidemiologia , Diálise Peritoneal/estatística & dados numéricos , Insuficiência Renal Crônica/sangue , Insuficiência Renal Crônica/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/sangue , Estudos de Casos e Controles , Causalidade , Comorbidade , Estudos Transversais , Intervalo Livre de Doença , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Periostite/diagnóstico , Prognóstico , Estudos Prospectivos , Insuficiência Renal Crônica/diagnóstico , Insuficiência Renal Crônica/reabilitação , Reprodutibilidade dos Testes , Medição de Risco , Sensibilidade e Especificidade , Taiwan/epidemiologia , Adulto Jovem
7.
Int J Antimicrob Agents ; 62(1): 106834, 2023 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-37127127

RESUMO

BACKGROUND: Molnupiravir is an essential oral antiviral agent against coronavirus disease 2019 (COVID-19); however, its real-world effectiveness has not been evaluated in patients undergoing haemodialysis (HD). METHODS: This multi-centre retrospective study, involving 225 patients undergoing HD with initially mild or asymptomatic COVID-19, was conducted to compare the risks of 30-day COVID-19-related acute care visits between patients receiving and not receiving molnupiravir. Patients who received molnupiravir were stratified by rapid antigen detection (RAD) test results on day 7 after disease onset to assess whether rapid molnupiravir introduction accelerated viral clearance. RESULTS: Thirty-day COVID-19-related acute care visits were reported in 9.41% and 21.74% of the molnupiravir and control groups, respectively, and use of molnupiravir markedly reduced the risk of acute care visits after adjusting for baseline characteristics via propensity score weighting [hazard ratio 0.218, 95% confidence interval (CI) 0.074-0.642; P=0.006]. The tolerability of molnupiravir in the enrolled patients was generally acceptable, with only 11.88% of molnupiravir users reporting mild adverse events. Moreover, rapid initiation of molnupiravir within 1 day of COVID-19 onset was an independent predictor of conversion to a negative RAD test result on day 7 after disease onset (odds ratio 6.207, 95% CI 2.509-15.358; P<0.001). CONCLUSIONS: Molnupiravir is well tolerated and decreases the medical needs in patients with COVID-19 undergoing HD. Furthermore, the rapid initiation of molnupiravir accelerates viral clearance in patients with COVID-19 undergoing HD. These findings highlight the therapeutic role of molnupiravir for this vulnerable population.


Assuntos
COVID-19 , Humanos , Estudos Retrospectivos , Diálise Renal , Resultado do Tratamento , Antivirais/uso terapêutico
8.
BMC Nephrol ; 13: 39, 2012 Jun 14.
Artigo em Inglês | MEDLINE | ID: mdl-22697882

RESUMO

BACKGROUND: It is well known that the quality of life of patients with chronic kidney disease can be improved by dialysis. While previous studies have used retrospective designs and adhered to a standard target prescribed by clinical guidelines, our study prospectively investigates the association between the adequacy of peritoneal dialysis (PD) and measures of nutritional status on quality-of-life domains in a cohort of incident PD patients. METHODS: It was a prospective 6-month observational study. Eighty incident PD participants who were treated in a hospital-based PD center were enrolled. The period of enrollment was January 2009-June 2010; follow-up continued until December 2010. PD adequacy indices, including Kt/V urea, weekly Ccr (WCcr), measures of nutritional status (albumin, BMI), and nPCR were measured at 1 month and 6 months after PD initiation. SF-36 health survey questionnaires were used to measure the quality of life. The outcomes were used to measure the changes in the domains of the SF-36 after 6 months of PD therapy. RESULTS: Seventy-seven incident patients who underwent PD for 6 months were included in the study. The mean age was 47.3 years, and the male-to-female ratio was 38:39. A peritoneal Kt/V urea value of 1.2, which was also the baseline cutoff value, was found to have the highest influence on SF-36 domains. Patients with baseline peritoneal Kt/V urea value of <1.2 showed improvement in the physical functioning and role limitation of physical functioning components after 6 months of PD. In contrast, patients with baseline peritoneal Kt/V urea values of ≥1.2 showed remarkable improvement in the general health, physical functioning, role limitation caused by physical problems, and bodily pain components. However, the trend of improvement decreased in patients with baseline nPCR of <1.2. Baseline renal WCcr did not influence the improvement in the SF-36 domains. LIMITATIONS: A small cohort and a short observation period. CONCLUSIONS: The baseline level of peritoneal Kt/V urea affected the components of the quality of life after PD initiation. In contrast, a lower baseline nPCR level was associated with deterioration in the quality of life after PD therapy.


Assuntos
Estado Nutricional/fisiologia , Diálise Peritoneal/efeitos adversos , Qualidade de Vida , Ureia/sangue , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/sangue , Estudos de Coortes , Feminino , Seguimentos , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Diálise Peritoneal/métodos , Estudos Prospectivos , Qualidade de Vida/psicologia , Adulto Jovem
9.
Nephrology (Carlton) ; 16(7): 663-71, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21777343

RESUMO

AIM: The aim of this analysis was to know whether these three cytokine polymorphisms, including interleukin-6 (IL-6; -572 G/C), tumour necrosis factor-α (TNF-α; -308 G/A), and IL-10 (-592 A/C) have an effect on baseline peritoneal transport property and longitudinal evolution of peritoneal function. METHODS: A total of 141 stable peritoneal dialysis (PD) patients with mean treatment duration of 84.4 ± 34.2 months were enrolled. We genotyped these three cytokine polymorphisms, together with clinical parameters that were included as factors affecting longitudinal change of property of peritoneal transport over the first 3 year period after commencing therapy. RESULTS: There was no significant association between genotypes and baseline peritoneal transport property. The -592 A/C polymorphism of IL-10 was associated with longitudinal change of peritoneal transport. The ratio of D/P creatinine was significantly higher in patients with AA than those with CC/CA genotypes at 12 months (0.65 ± 0.11 vs 0.62 ± 0.09, P = 0.048) and 24 months (0.64 ± 0.12 vs 0.59 ± 0.09, P = 0.018). In addition, patients with increased peritoneal transport have greater frequency distribution of AA genotype and A allele. Logistic regression analysis revealed that -592 A allele was an independent predictor for the increase in D/P creatinine over the first 12 month period (odds ratio: 2.482, P = 0.017). There was no correlation between either polymorphism of IL-6 -572 (G/C) or TNF-α-308 (G/A) and longitudinal change of peritoneal function. CONCLUSIONS: Single nucleotide polymorphism of IL-10 -592 (A/C) was associated with longitudinal evolution of peritoneal transport rate in PD patients rather than the baseline peritoneal characteristics.


Assuntos
Interleucina-10/genética , Falência Renal Crônica/terapia , Diálise Peritoneal , Peritônio/metabolismo , Polimorfismo de Nucleotídeo Único , Adulto , Idoso , Transporte Biológico , Distribuição de Qui-Quadrado , Feminino , Frequência do Gene , Genótipo , Humanos , Interleucina-6/genética , Falência Renal Crônica/genética , Falência Renal Crônica/imunologia , Falência Renal Crônica/metabolismo , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Permeabilidade , Fenótipo , Regiões Promotoras Genéticas , Estudos Retrospectivos , Taiwan , Fatores de Tempo , Resultado do Tratamento , Fator de Necrose Tumoral alfa/genética
10.
Nephron Clin Pract ; 111(4): c247-52, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19293593

RESUMO

BACKGROUND: Iron deficiency is the most common factor associated with erythropoietin (EPO) hyporesponsiveness. Current iron indices are inadequate to demonstrate the status or utility of iron in erythropoiesis. The aims of this study are to investigate the value of the reticulocyte hemoglobin content, RET-Y, in hemodialysis (HD) patients and compare the levels with conventional iron indices. METHODS: HD patients (n = 289) were divided into 4 groups according to serum ferritin (cutoff value 100 ng/ml) and transferrin saturation (TSAT, cutoff value 20%). The RET-Y value, hemogram and biochemical data were determined and compared between groups. Factors associated with RET-Y were examined. RESULTS: The mean RET-Y value was 1,716 +/- 125 AU. Patients with absolute iron deficiency had lower RET-Y levels and mean corpuscular volume (MCV). Patients with functional iron deficiency had a lower reticulocyte production index and serum albumin levels. MCV, mean corpuscular hemoglobin concentration (MCHC) and albumin were independently correlated with the RET-Y level (all p < 0.001). EPO-independent patients had low iron indices and low RET-Y levels, but a higher reticulocyte production index and albumin levels were noted. CONCLUSION: RET-Y levels in HD patients were close to that of the normal population. Low RET-Y levels were observed in patients with absolute iron deficiency and also in EPO-independent patients with low ferritin and low TSAT. There was a strong association between the serum albumin and RET-Y levels in chronic HD patients.


Assuntos
Anemia Ferropriva/complicações , Anemia Ferropriva/diagnóstico , Hemoglobinas/análise , Falência Renal Crônica/complicações , Falência Renal Crônica/diagnóstico , Diálise Renal , Reticulócitos/metabolismo , Anemia Ferropriva/sangue , Feminino , Humanos , Falência Renal Crônica/sangue , Masculino , Pessoa de Meia-Idade , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
11.
J Negat Results Biomed ; 8: 10, 2009 Nov 05.
Artigo em Inglês | MEDLINE | ID: mdl-19889239

RESUMO

BACKGROUND: Mitochondria (mt) are highly susceptible to reactive oxygen species (ROS). In this study, we investigated the association between a region within the displacement loop (D-loop) in mtDNA that is highly susceptible to ROS and oxidative stress markers in chronic dialysis patients. We enrolled 184 chronic dialysis patients and 213 age-matched healthy subjects for comparison. Blood levels of oxidative stress markers, such as thiobarbituric acid reactive substances (TBARS) and free thiol, and the mtDNA copy number were determined. A mononucleotide repeat sequence (CCCC...CCCTCCCCCC) between nucleotides 303 and 316-318 (D310) was identified in mtDNA. RESULTS: Depending on alterations in the D310 mononucleotide repeat, subjects were categorized into 4 subgroups: 7-C, 8-C, 9 or 10-C, and T-to-C transition. Oxidative stress was higher in chronic dialysis patients, evidenced by higher levels of TBARS and mtDNA copy number, and a lower level of free thiol. The distribution of 7-C, 8-C, and 9-10C in dialysis and control subjects was as follows: 7-C (38% vs. 31.5%), 8-C (35.3% vs. 43.2%), and 9-10C (24.5% vs. 22.1%). Although there were significant differences in levels of TBARS, free thiol, and the mtDNA copy number in the D310 repeat subgroups (except T-to-C transition) between dialysis patients and control subjects, post hoc analyses within the same study cohort revealed no significant differences. CONCLUSION: Although oxidative stress was elevated in chronic dialysis patients and resulted in a compensatory increase in the mtDNA copy number, homopolymeric C repeats in the mtDNA region (D310), susceptible to ROS, were not associated with oxidative stress markers in these patients.


Assuntos
DNA Mitocondrial/genética , Mutação , Estresse Oxidativo , Diálise Renal , Sequências Repetitivas de Ácido Nucleico , Adulto , Sequência de Bases , Estudos de Casos e Controles , Estudos de Coortes , Primers do DNA , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Espécies Reativas de Oxigênio/metabolismo , Taiwan
12.
J Ren Nutr ; 19(3): 220-7, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19243976

RESUMO

OBJECTIVE: Both chronic inflammation and dysregulation of bone and mineral metabolism are closely related with long-term outcomes of dialysis patients. Our objective was to investigate the relationship between these two abnormalities. DESIGN: This was a cross-sectional study. SETTING: This study was performed at a hospital-based hemodialysis center. PATIENTS: We enrolled 448 (male, 198; female, 250) clinically stable hemodialysis patients. Patients with chronic inflammatory disease, malignancy, or viral hepatitis were excluded. Their age (mean +/- SD) was 57.4 +/- 12.5 years. MAIN OUTCOME MEASURES: Biomarkers, including high-sensitivity C-reactive protein (hsCRP), total calcium, phosphate, and intact parathyroid hormone levels, were measured and compared with the recommended range in the K/DOQI guidelines. Correlations between these parameters were analyzed, and factors independently associated with hsCRP and the calcium phosphate product (Ca x P) were identified by regression analysis. RESULTS: Most patients did not achieve the K/DOQI recommended therapeutic range in the four parameters, and only 50 patients (11%) met their treatment goals. The hsCRP level was directly related to calcium, phosphate, and Ca x P. Patients who achieved the guidelines' range had lower hsCRP levels (1.97 mg/L vs. 2.71 mg/L, P < .05). A high hsCRP level (> or = 10 mg/L) was associated with higher calcium, phosphate, and Ca x P levels, and lower albumin levels. Serum albumin, Ca x P, alkaline phosphatase, and diabetes independently predicted hsCRP levels. CONCLUSION: There is a strong association between chronic inflammation and the disturbance of bone mineral metabolism in chronic hemodialysis patients.


Assuntos
Osso e Ossos/metabolismo , Proteína C-Reativa/metabolismo , Falência Renal Crônica/sangue , Falência Renal Crônica/terapia , Minerais/sangue , Diálise Renal , Biomarcadores/sangue , Cálcio/sangue , Doença Crônica , Estudos Transversais , Feminino , Humanos , Inflamação/sangue , Inflamação/complicações , Falência Renal Crônica/complicações , Masculino , Pessoa de Meia-Idade , Fosfatos/sangue
13.
PLoS One ; 14(11): e0224785, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31697719

RESUMO

An ethnicity-based reference range for normal renal size is fundamental for ultrasonographic assessment. Herein, we aimed to establish a Chinese renal reference by a large sample size, as well as to elucidate the relationship of renal dimension to age and body indices, with the aid of a comprehensive literature review. Records of 3707 healthy cases were obtained from health evaluation centers of Kaohsiung and Linkuo Chang Gung Memorial Hospitals. As a result, the mean right renal length was 10.62±0.69 cm, left renal length 10.76±0.70 cm, right renal width 4.78±0.75 cm, and left renal width 5.10±0.64 cm. Renal size was well-correlated curvilinearly to age, while linearly to body height, body weight, and body mass index. Renal size increases and then decreases with aging, and significant variations of renal size exist among different ethnicities. Our work provides a reliable reference range for renal size in the Chinese population, and valid relationships between renal dimensions and other parameters.


Assuntos
Índice de Massa Corporal , Rim/diagnóstico por imagem , Ultrassonografia , Fatores Etários , Estatura , Peso Corporal , Feminino , Humanos , Rim/patologia , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Valores de Referência , Análise de Regressão , Estudos Retrospectivos , Taiwan
14.
Am J Nephrol ; 28(5): 853-9, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18547945

RESUMO

BACKGROUND/AIMS: The influence of oxidative stress and peritoneal clearance on alterations in mitochondrial DNA (mtDNA) copy number in continuous ambulatory peritoneal dialysis (CAPD) patients was investigated. METHODS: Ninety-one CAPD patients (age, 30-57 years) and 99 age-matched healthy subjects were enrolled. Biochemical variables, plasma thiobarbituric-acid-reactive substances (TBARS), free thiol levels and mtDNA copy number in peripheral leukocytes were measured. RESULTS: CAPD patients showed higher TBARS levels, lower free thiol levels and a higher mtDNA copy number than control subjects. Plasma TBARS levels and peritoneal urea clearance were significant factors contributing positively to leukocyte mtDNA copy number (p = 0.024, R(2) = 0.238). The CAPD patients were further categorized into 4 groups depending on whether the TBARS and free thiol plasma levels were above or below the mean values for these parameters. Patients with higher TBARS levels and lower free thiol levels had a significantly higher number of leukocyte mtDNA copies than patients with lower TBARS levels and higher free thiol levels (multi-covariate ANOVA, p = 0.008). CONCLUSION: This study demonstrated that CAPD patients have higher oxidative stress than healthy subjects; such elevated oxidative stress and peritoneal urea clearance have a positive correlation with mtDNA copy number in peripheral leukocytes.


Assuntos
Biomarcadores/sangue , DNA Mitocondrial/genética , Estresse Oxidativo/fisiologia , Diálise Peritoneal Ambulatorial Contínua , Ureia/metabolismo , Adulto , Feminino , Dosagem de Genes , Humanos , Leucócitos , Masculino , Pessoa de Meia-Idade , Compostos de Sulfidrila/sangue , Substâncias Reativas com Ácido Tiobarbitúrico/análise
15.
J Nephrol ; 21(1): 74-80, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18264939

RESUMO

BACKGROUND: Reviewing laboratory data is a key method in dialysis research. However, data collection via a traditional prospective study is invariably costly in terms of money and time. Abstracting data from existing databases using multiple methods to identify underlying knowledge offers an alternative means of reducing the medical uncertainties. METHODS: Laboratory data covering the previous 1-year period before dialysis for 212 hemodialysis (HD) patients were adopted as the study data. The original 86 examination items (input variables), 1 assigned output distinguishing variable and 1,292 records were abstracted into a 13x931 data set (13 variables and 931 records). A transformed data set comprising a binary code of original values was then prepared. This work compared the data between 2 groups, 2-month-0 (records dated earlier than 2 months before HD started) and 2-month-1 (records dated within a period of 2 months). To avoid effects from missing values in the database, 4 analysis methods--namely t-test, ANOVA, Kruskal-Wallis H test and Spearman correlation--were applied to both the original scaling and the transformed data. RESULTS: Through appropriate data cleansing, 12 out of 86 examination items can be used as index factors to distinguish patient disease condition between 2-month-0 and 2-month-1. Of these, after data analysis and data format comparison, 4 items--serum potassium, serum calcium, red blood cell count and platelet count--rather than the traditional kidney function, were shown to be the most distinguishing variables. The transformed data provided more consistent results than the original scaling. However, original scaling yielded rich information and results that were consistent with current medical knowledge. CONCLUSIONS: Reviewing different data formats via a multimethod approach can reduce uncertainties associated with real world databases, and thus achieve enhanced medical care.


Assuntos
Coleta de Dados , Nefropatias/terapia , Sistemas Computadorizados de Registros Médicos , Doença Crônica , Interpretação Estatística de Dados , Humanos
16.
PLoS One ; 13(1): e0190079, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29293548

RESUMO

BACKGROUND: Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication of long-term peritoneal dialysis (PD). However, previous studies reported large variations in its mortality rates that may associate with a different degree of EPS severity. This study reports the incidence and outcomes of EPS and identifies the risk factors associated with severe EPS. METHODS: We retrospectively analyzed clinical data of EPS patients from 3 medical centers in Taiwan from January 1982 to September 2015, and classified patients as having mild/moderate or severe EPS. Patients with intractable intestinal obstruction/gut-related sepsis that needed surgical intervention or resulted in mortality were in severe EPS group. Follow-up for outcome was through December 31, 2015. Clinical characteristics, peritoneal dialysis (PD)-related parameters, biochemical and imaging results were analyzed and compared between groups. RESULTS: Fifty-eight of 3202 patients undergoing PD during the study period had EPS (prevalence 1.8%). The incidence of EPS increased for patients on PD for >6-8 years (≤6 yrs. vs. >6-8 yrs., 0.0% vs. 1.8%, p = 0.001). Relative to those on PD for >6-8 years, the risk of EPS significantly increased with PD duration longer than 10 years (>10-12 years vs. >6-8 years: OR: 5.5, 95% CI: 1.7-17.1, p < 0.01). Twenty-three patients fulfilled the criteria for severe EPS. The overall mortality rate of EPS was 35% (20/58), and was 74% (17/23) in the severe EPS group. The average serum levels of C-reactive protein (CRP) and intact-parathyroid hormone (i-PTH), which were checked every 3~6 months within one year before diagnosis of EPS, were higher in severe EPS group than in mild/moderate group (p = 0.02, p = 0.08, respectively). Multivariate analysis revealed severe EPS was independently associated with bowel tethering (based on CT), presentation with bloody ascites, diagnosis of EPS after withdrawal from PD, and i-PTH ≥ 384 pg/mL. Receiver operating characteristic analysis indicated that presentation with 2 or more of the 5 risk factors (EPS diagnosis after PD withdrawal, bloody ascites, bowel tethering, CRP ≥ 29 mg/L, and i-PTH ≥ 384 pg/mL) had a good accuracy (AUC = 0.80, p = 0.001) for prediction of severe EPS. CONCLUSIONS: The incidence of EPS increases with PD duration. Severe EPS has high mortality rate and is associated with bowel tethering, presentation of bloody ascites, diagnosis after PD withdrawal, and higher serum levels of i-PTH before EPS diagnosis. Having 2 or more of the 5 risk factors can provide a good accuracy for prediction of severe EPS.


Assuntos
Fibrose Peritoneal/fisiopatologia , Adulto , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Fibrose Peritoneal/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Índice de Gravidade de Doença , Taiwan/epidemiologia
17.
Am J Trop Med Hyg ; 77(1): 151-8, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17620647

RESUMO

To investigate clinical course and outcome of dengue with acute respiratory failure (ARF), and to identify related risk factors for acquiring ARF in dengue, we retrospectively studied 11 dengue patients with ARF. From June to December 2002, a total of 606 adult patients were diagnosed as having dengue. Eleven (1.8%) of 606 dengue patients had complications of ARF. The main causes of ARF were sepsis (n = 6, 54.5%) and upper gastrointestinal (UGI) bleeding (n = 3, 27.3%). The mortality rate was 72.7% (n = 8). Additionally, univariate analysis showed that age, dyspnea, cough, prothrombin time, activated partial thromboplastin time, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, creatinine, albumin, renal insufficiency, acute renal failure, acute hepatic failure, UGI bleeding, and combination bacterial infection were significantly predictive variables associated with dengue patients with ARF.


Assuntos
Dengue/epidemiologia , Insuficiência Respiratória/epidemiologia , Adulto , Idoso , Análise Química do Sangue , Dengue/sangue , Dengue/complicações , Dengue/mortalidade , Feminino , Humanos , Masculino , Prontuários Médicos , Pessoa de Meia-Idade , Insuficiência Respiratória/sangue , Insuficiência Respiratória/complicações , Insuficiência Respiratória/mortalidade , Estudos Retrospectivos , Fatores de Risco , Taiwan/epidemiologia
18.
Mediators Inflamm ; 2007: 19891, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-18288267

RESUMO

AIMS: chronic inflammation contributes significantly to the morbidity and mortality of chronic hemodialysis patients. A recent research has shown that adipokines were associated with inflammation in these patients. We aim to investigate whether biomarkers of inflammation, adipokines, and clinical features can predict the outcome of hemodialysis patients. MATERIALS AND METHODS: we enrolled 181 hemodialysis patients (men: 97, mean age: 56.3+/-13.6) and analyzed predictors of long-term outcomes. RESULTS: during the 3-year followup period, 41 patients died; the main causes of death were infection and cardiovascular disease. Elevated serum levels of hsCRP and albumin and advanced age were highly associated with death (all P<.001). Leptin and adiponectin levels were not significantly different between deceased patients and survivors. Cox-regression analysis indicated that age, diabetes, albumin level, and hsCRP were independent factors predicting mortality. CONCLUSION: the presence of underlying disease, advanced age, and markers of chronic inflammation is strongly related to survival rate in long-term hemodialysis patients.


Assuntos
Adipocinas/metabolismo , Inflamação/metabolismo , Nefropatias/sangue , Nefropatias/mortalidade , Diálise Renal/métodos , Adulto , Idoso , Biomarcadores/metabolismo , Feminino , Humanos , Hipoalbuminemia/metabolismo , Nefropatias/complicações , Masculino , Pessoa de Meia-Idade , Análise de Regressão , Fatores de Tempo , Resultado do Tratamento
19.
Sci Rep ; 7: 43314, 2017 03 03.
Artigo em Inglês | MEDLINE | ID: mdl-28256582

RESUMO

The relationship between serum alkaline phosphatase (ALP) concentrations and mortality in peritoneal dialysis (PD) patients is rarely reported. We enrolled 667 PD patients in one PD centre in Taiwan to retrospectively examine the association between three ALP concentrations (baseline, time-averaged, time-dependent) and mortality over a 5-year period (2011-2015). Baseline data collection included demographics, clinical, and laboratory parameters. Multivariable-adjusted Cox models were used to analyse the association. Four ALP quartiles were defined at the baseline: ≤62, 63-82, 83-118, and ≥119 U/L. Of 667 patients, 65 patients died, of which 8 patients died due to cardiovascular disease. Females were predominant in the higher ALP quartiles, and 24-h urine volume was significantly proportionately decreased in the higher ALP quartiles. ALP quartiles expressed by the three models were not associated with all-cause or cardiovascular mortalities after adjusting for demographics, liver function, bone metabolism, mortality, hemoglobin, and 24-h urine volume. In conclusion, ALP concentrations were not associated with death risk in PD patients over the 5-year period.


Assuntos
Fosfatase Alcalina/sangue , Doenças Cardiovasculares/mortalidade , Falência Renal Crônica/terapia , Diálise Peritoneal/mortalidade , Adulto , Idoso , Biomarcadores/sangue , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/diagnóstico , Causas de Morte , Feminino , Hemoglobinas/metabolismo , Humanos , Falência Renal Crônica/fisiopatologia , Falência Renal Crônica/cirurgia , Testes de Função Hepática , Masculino , Pessoa de Meia-Idade , Prognóstico , Modelos de Riscos Proporcionais , Estudos Retrospectivos , Fatores de Risco , Taiwan
20.
Biomed Res Int ; 2016: 6453803, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27999806

RESUMO

Background. We examined the changes in circulating fibroblast growth factor 23 (FGF23) and Klotho concentrations in hemodialysis patients after parathyroidectomy (PTX). Methods. We enrolled a cohort of hemodialysis patients who received PTX. Postoperatively, patients received calcium supplements and/or vitamin D analogue (calcitriol) to maintain serum calcium within 7.0-8.0 mg/dL. Information on clinical parameters including bone-mineral metabolic variables was collected pre-PTX and on days 5 and 90 after PTX. Concomitantly, serum full-length FGF23 and α-Klotho levels were measured. The relationship between FGF23 and clinical parameters was analyzed by single linear regression. Results. Forty-six participants (33 women; 13 men) were enrolled in the study. Their mean age was 56.49 years. Serum FGF23 and α-Klotho concentrations were elevated on days 5 and 90 after PTX compared to baseline (p > 0.05). Serum FGF23 concentrations negatively correlated with serum calcium concentrations pre-PTX (Beta -0.31; R2 0.0949; p = 0.040), day 5 post-PTX (Beta -0.31; R2 0.0982; p = 0.036), and day 90 post-PTX (Beta -0.39; R2 0.1528; p = 0.008). Conclusions. There was no change in circulating FGF23 and Klotho concentrations after PTX in hemodialysis patients given postoperative calcium supplements and/or vitamin D analogue. Serum FGF23 concentrations pre-PTX and at days 5 and 90 after PTX were inversely related to serum calcium concentrations.


Assuntos
Fatores de Crescimento de Fibroblastos/sangue , Glucuronidase/sangue , Hiperparatireoidismo/sangue , Paratireoidectomia , Diálise Renal , Insuficiência Renal Crônica/sangue , Idoso , Calcitriol/administração & dosagem , Feminino , Fator de Crescimento de Fibroblastos 23 , Humanos , Hiperparatireoidismo/etiologia , Hiperparatireoidismo/terapia , Proteínas Klotho , Masculino , Pessoa de Meia-Idade , Insuficiência Renal Crônica/complicações , Insuficiência Renal Crônica/terapia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA